References
Roth C, Ferbert A (2011) The posterior reversible encephalopathy syndrome: what’s certain, what’s new? Pract Neurol 11(3):136–144
Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin MS, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494–500
Jaing TH, Lin JL, Lin YP, Yang SH, Lin JJ, Hsia SH (2009) Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia. J Pediatr Hematol Oncol 31(12):955–956
Piccin A, Cortelazzo S, Rovigatti U, Bourke B, Smith OP (2010) Immunosuppressive treatments in Crohn’s disease induce myelodysplasia and leukaemia. Am J Hematol 85(8):634
Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, Benoit Y, Robert A, Manel AM, Vilmer E, Otten J, Philippe N (2002) Comparison of Escherichia coli–asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer—Children’s Leukemia Group phase 3 trial. Blood 99(8):2734–2739
Incecik F, Hergüner MO, Altunbasak S, Erbey F, Leblebisatan G (2009) Evaluation of nine children with reversible posterior encephalopathy syndrome. Neurol India 57(4):475–478
Shim YS, Park CO, Hyun DK, Park HC, Yoon SH (2007) What are the causative factors for a slow, progressive enlargement of a chronic subdural hematoma? Yonsei Med J 48(2):210–217
Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, Gnant MF, Alexander HR (2002) Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100(4):1334–1339
Tanaka M, Yamanishi H (1993) The expression of tissue factor antigen and activity on the surface of leukemic cells. Leuk Res 17(2):103–111
Attarbaschi A, Mann G, Kronberger M, Witt V, Gadner H, Dworzak M (2003) Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000. Klin Padiatr 215(6):321–326
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piccin, A., Dossi, R.C., Cassibba, V. et al. Anti-thrombin-III reduction and posterior reversible encephalopathy syndrome (PRES) in acute lymphoblastic leukaemia (ALL). New insight into PRES pathophysiology. Ann Hematol 91, 1153–1155 (2012). https://doi.org/10.1007/s00277-011-1376-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-011-1376-z